ACORN FINANCIAL ADVISORY SERVICES INC /ADV
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1018561
Reston, VA
Position in REGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$936,557
-$224,720 QoQ
Shares Held
1,502
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#657
of 1,322 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACORN FINANCIAL ADVISORY SERVICES INC /ADV holds $936,557 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,502 | $936,557 |
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $936,557 | 1,502 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,161,277 | 1,503 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,160,120 | 1,503 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $844,529 | 1,502 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $788,550 | 1,502 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $952,613 | 1,502 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,141,152 | 1,602 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,684,086 | 1,602 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,684,801 | 1,603 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,542,871 | 1,603 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,407,020 | 1,602 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,316,736 | 1,600 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,149,664 | 1,600 | Shares | Sole | 2023-07-20 | |
| No filing history on record for this holder in this stock. | ||||||